Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-20-011830

EVP/Chief Scientific Officer sold 10,000 shares at $45.00 ($450,000)

  • EVP/Chief Scientific Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Albright Charles · EVP/Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-09 Exercise or conversion : show line 1 in the form +10,000 $16.51 $165,100 34,907 D
2020-12-09 Sale : show line 2 in the form −10,000 $45.00 $450,000 24,907 D
Open-market sales · 10,000 sh · avg $45.00 · $450,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-09 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −10,000 155,000 D
Loading xslF345X03/edgar.xml…